[Federal Register Volume 67, Number 26 (Thursday, February 7, 2002)]
[Notices]
[Page 5837]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-2897]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel, Multicenter Study of Hydroxyurea (MSH), 
Patients Follow Up Extension 1.
    Date: February 20, 2002.
    Time: 1:00 PM to 3:30 PM.
    Agenda: To review and evaluate contract proposals.
    Place: Rockledge II, Bethesda, MD 20892, (Telephone Conference 
Call).
    Contact Person: Robert B. Moore, PHD, Scientific Review 
Administrator, Review Branch, Room 7192, Division of Extramural 
Affairs, National Heart, Lung, and Blood Institute, National 
Institutes of Health, 6701 Rockledge Drive, MSC 7924, Bethesda, MD 
20892, 301-435-0287.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)
    Dated: January 29, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-2897 Filed 2-6-02; 8:45 am]
BILLING CODE 4140-01-M